Literature DB >> 27023275

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions.

Mohameedyaseen Syedbasha1, Janina Linnik2, Deanna Santer3, Daire O'Shea4, Khaled Barakat5, Michael Joyce3, Nina Khanna6, D Lorne Tyrrell3, Michael Houghton3, Adrian Egli7.   

Abstract

A comprehensive understanding of signaling pathways requires detailed knowledge regarding ligand-receptor interaction. This article describes two fast and reliable point-by-point protocols of enzyme-linked immunosorbent assays (ELISAs) for the investigation of ligand-receptor interactions: the direct ligand-receptor interaction assay (LRA) and the competition LRA. As a case study, the ELISA based analysis of the interaction between different lambda interferons (IFNLs) and the alpha subunit of their receptor (IL28RA) is presented: the direct LRA is used for the determination of dissociation constants (KD values) between receptor and IFN ligands, and the competition LRA for the determination of the inhibitory capacity of an oligopeptide, which was designed to compete with the IFNLs at their receptor binding site. Analytical steps to estimate KD and half maximal inhibitory concentration (IC50) values are described. Finally, the discussion highlights advantages and disadvantages of the presented method and how the results enable a better molecular understanding of ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023275      PMCID: PMC4828978          DOI: 10.3791/53575

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

Review 1.  The structure of human interferon lambda and what it has taught us.

Authors:  Hans Henrik Gad; Ole Jensen Hamming; Rune Hartmann
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

2.  Positively charged peptides can interact with each other, as revealed by solid phase binding assays.

Authors:  Joseph Rosenbluh; Anat Kapelnikov; Deborah E Shalev; Marco Rusnati; Antonella Bugatti; Abraham Loyter
Journal:  Anal Biochem       Date:  2006-03-20       Impact factor: 3.365

3.  Thermostability of salt bridges versus hydrophobic interactions in proteins probed by statistical potentials.

Authors:  Benjamin Folch; Marianne Rooman; Yves Dehouck
Journal:  J Chem Inf Model       Date:  2007-12-28       Impact factor: 4.956

Review 4.  Analysis of cell-adhesion molecule interactions using surface plasmon resonance.

Authors:  P A van der Merwe; A N Barclay
Journal:  Curr Opin Immunol       Date:  1996-04       Impact factor: 7.486

5.  Interactions between ionizable amino acid side chains at a lipid bilayer-water interface.

Authors:  Olga Yuzlenko; Themis Lazaridis
Journal:  J Phys Chem B       Date:  2011-11-01       Impact factor: 2.991

Review 6.  Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members.

Authors:  Pascal Schneider; Laure Willen; Cristian R Smulski
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

7.  Importance of two buried salt bridges in the stability and folding pathway of barnase.

Authors:  A C Tissot; S Vuilleumier; A R Fersht
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

Review 8.  The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; D Lorne Tyrrell; Michael Houghton
Journal:  Emerg Microbes Infect       Date:  2014-07-16       Impact factor: 7.163

9.  IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; Khaled Barakat; Mohammedyaseen Syedbasha; Madeleine Vollmer; Aliyah Baluch; Rakesh Bhat; Jody Groenendyk; Michael A Joyce; Luiz F Lisboa; Brad S Thomas; Manuel Battegay; Nina Khanna; Thomas Mueller; D Lorne J Tyrrell; Michael Houghton; Atul Humar; Deepali Kumar
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

10.  Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.

Authors:  Aviad Levin; Zvi Hayouka; Markus Helfer; Ruth Brack-Werner; Assaf Friedler; Abraham Loyter
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more
  13 in total

1.  Capsid-specific nanobody effects on HIV-1 assembly and infectivity.

Authors:  Ayna Alfadhli; CeAnn Romanaggi; Robin Lid Barklis; Ilaria Merutka; Timothy A Bates; Fikadu G Tafesse; Eric Barklis
Journal:  Virology       Date:  2021-07-05       Impact factor: 3.513

Review 2.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

3.  Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.

Authors:  Deanna M Santer; Gillian E S Minty; Dominic P Golec; Julia Lu; Julia May; Afshin Namdar; Juhi Shah; Shokrollah Elahi; David Proud; Michael Joyce; D Lorne Tyrrell; Michael Houghton
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

4.  Pembrolizumab microgravity crystallization experimentation.

Authors:  Paul Reichert; Winifred Prosise; Thierry O Fischmann; Giovanna Scapin; Chakravarthy Narasimhan; April Spinale; Ray Polniak; Xiaoyu Yang; Erika Walsh; Daya Patel; Wendy Benjamin; Johnathan Welch; Denarra Simmons; Corey Strickland
Journal:  NPJ Microgravity       Date:  2019-12-02       Impact factor: 4.415

5.  Quantification of Receptor Occupancy by Ligand-An Understudied Class of Potential Biomarkers.

Authors:  Suresh Veeramani; George J Weiner
Journal:  Cancers (Basel)       Date:  2020-10-13       Impact factor: 6.639

Review 6.  Interferon lambda in inflammation and autoimmune rheumatic diseases.

Authors:  Rishi R Goel; Sergei V Kotenko; Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2021-04-27       Impact factor: 20.543

7.  A Protein-Engineered, Enhanced Yeast Display Platform for Rapid Evolution of Challenging Targets.

Authors:  Jiří Zahradník; Debabrata Dey; Shir Marciano; Lucie Kolářová; Chloé I Charendoff; Agathe Subtil; Gideon Schreiber
Journal:  ACS Synth Biol       Date:  2021-11-22       Impact factor: 5.110

Review 8.  Bioassay Development for Bispecific Antibodies-Challenges and Opportunities.

Authors:  Ames C Register; Somayeh S Tarighat; Ho Young Lee
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 9.  Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.

Authors:  Laura A Novotny; John Grayson Evans; Lishan Su; Haitao Guo; Eric G Meissner
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

10.  PfEMP1 A-Type ICAM-1-Binding Domains Are Not Associated with Cerebral Malaria in Beninese Children.

Authors:  V Joste; E Guillochon; J Fraering; B Vianou; L Watier; S Jafari-Guemouri; M Cot; S Houzé; A Aubouy; J F Faucher; N Argy; G I Bertin
Journal:  mBio       Date:  2020-11-17       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.